Generic Name: delavirdine

Pronunciation: N/A

Abbreviation: DLV

Other Market Name: N/A

Drug Class: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Pharmaceutical Company: ViiV Healthcare

Approval Status: Approved

Generic Version Available: No

Experimental Code: N/A

Drug Recommendation

Not part of a recommended or alternative treatment regimen for antiretroviral-naive people living with HIV, according to the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents. Visit for the full DHHS guidelines.

General Info

Rescriptor is an HIV medication. It is in a category of HIV medicines called non-nucleoside reverse transcriptase inhibitors. Rescriptor was approved by the U.S. Food and Drug Administration for use by people living with HIV in 1997.

Rescriptor must be used in combination with other HIV drugs.


Adult Dose: Two 200mg tablets three times a day or four 100mg tablets three times a day.

Pediatric Dose: N/A

Dosing Info: Take with or without food.

Side Effects

The most common side effect of Rescriptor is mild-to-moderate skin rash. In a small number of patients, rash has been serious and resulted in death. Therefore, if you develop a rash with any of the following symptoms, call your doctor immediately: general ill feeling, fever, muscle or joint aches, blisters, mouth sores, conjunctivitis (inflammation of the inner surface of the eyelids), swelling of the face, tiredness.

Other possible side effects include nausea, diarrhea, headache, and fatigue.

Drug Interactions

For a review of drug interactions, including prescription and over-the-counter medications and supplements that should not be taken with Rescriptor or may require dose adjustments, consult the Rescriptor package insert:

Other Info

Before taking this medication, tell your doctor if you have kidney disease or liver disease (including hepatitis B). In addition, tell your doctor if you are pregnant or planning to become pregnant, if you are breastfeeding, and all your medical conditions, including all prescription and over-the-counter medications and supplements you are taking.

For More Info:

Co-Pay Program Info:

Patient Assistance Program Info:

Last Revised: July 15, 2016